Zurich, 23 May 2023: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) is providing an update on its financial and operational condition.
The Company reports that it is over-indebted according to article 725b of the Swiss Code of Obligations, and the Company has received a court order regarding its solvency, and to deliver books and records within 10 days. Additionally, the Company’s auditor, Grant Thornton, has resigned.
“We regret the situation, and we’ve been battling it hard to make it work between an Indonesian commercial opportunity and a Swiss company and this is as far as it goes,” said Mr Steven Goh, CEO of Achiko AG. “We believe that there’s a valuable combination of assets within the Group, and hope there may yet be an opportunity for our long suffering shareholders and creditors.”
ABOUT ACHIKO AG
Achiko AG (SIX: ACHI.SW; www.achiko.com) is developing disruptive diagnostic solutions that put people first. The Company’s lead product, AptameX™, is a rapid, reliable Covid-19 test with a companion app, Teman Sehat™, offering a user-friendly digital health passport. AptameX™ and Teman Sehat™ were launched in Indonesia in mid-2021 and AptameX™ received the CE Mark in the European Union in May 2022.
Headquartered in Zurich, Achiko has offices in Jakarta, and staff around the world.
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.